Compare PHAT & SLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PHAT | SLI |
|---|---|---|
| Founded | 2018 | 1998 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 590.6M | 524.3M |
| IPO Year | 2019 | 2011 |
| Metric | PHAT | SLI |
|---|---|---|
| Price | $5.22 | $1.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 6 |
| Target Price | ★ $20.05 | $4.49 |
| AVG Volume (30 Days) | ★ 1.8M | 1.7M |
| Earning Date | 10-29-2026 | 08-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.72 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $175,110,000.00 | N/A |
| Revenue This Year | $79.63 | N/A |
| Revenue Next Year | $54.71 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 216.93 | N/A |
| 52 Week Low | $5.02 | $1.32 |
| 52 Week High | $18.31 | $6.00 |
| Indicator | PHAT | SLI |
|---|---|---|
| Relative Strength Index (RSI) | 30.97 | 42.68 |
| Support Level | $5.02 | $1.32 |
| Resistance Level | $11.85 | $1.58 |
| Average True Range (ATR) | 0.62 | 0.09 |
| MACD | -0.08 | 0.02 |
| Stochastic Oscillator | 7.10 | 50.00 |
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
Standard Lithium Corp is engaged in the exploration and development of lithium brine properties in the United States. The company's flagship projects are located in the Smackover Formation, a world-class lithium brine asset, focused in Arkansas and Texas. It is also Standard Lithium is advancing the South West Arkansas project, a greenfield project located in southern Arkansas, and strengthening lithium brine prospects in East Texas. Its other project comprises the Lanxess Property Project; and California Properties. The technologies used for the projects are : Direct Lithium Extraction; Demonstration Plant; SiFT; Lithium Sulfide; and Aqualung.